Cite
Survival outcomes and prognostic factors in mycosis fungoides/Sézary syndrome: validation of the revised International Society for Cutaneous Lymphomas/European Organisation for Research and Treatment of Cancer staging proposal.
MLA
Agar, Nita Sally, et al. “Survival Outcomes and Prognostic Factors in Mycosis Fungoides/Sézary Syndrome: Validation of the Revised International Society for Cutaneous Lymphomas/European Organisation for Research and Treatment of Cancer Staging Proposal.” Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, vol. 28, no. 31, Nov. 2010, pp. 4730–39. EBSCOhost, https://doi.org/10.1200/JCO.2009.27.7665.
APA
Agar, N. S., Wedgeworth, E., Crichton, S., Mitchell, T. J., Cox, M., Ferreira, S., Robson, A., Calonje, E., Stefanato, C. M., Wain, E. M., Wilkins, B., Fields, P. A., Dean, A., Webb, K., Scarisbrick, J., Morris, S., & Whittaker, S. J. (2010). Survival outcomes and prognostic factors in mycosis fungoides/Sézary syndrome: validation of the revised International Society for Cutaneous Lymphomas/European Organisation for Research and Treatment of Cancer staging proposal. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, 28(31), 4730–4739. https://doi.org/10.1200/JCO.2009.27.7665
Chicago
Agar, Nita Sally, Emma Wedgeworth, Siobhan Crichton, Tracey J Mitchell, Michael Cox, Silvia Ferreira, Alistair Robson, et al. 2010. “Survival Outcomes and Prognostic Factors in Mycosis Fungoides/Sézary Syndrome: Validation of the Revised International Society for Cutaneous Lymphomas/European Organisation for Research and Treatment of Cancer Staging Proposal.” Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 28 (31): 4730–39. doi:10.1200/JCO.2009.27.7665.